Sclerostin is a delayed secreted product of osteocytes that inhibits bone formation-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Sclerostin is a delayed secreted product of osteocytes that inhibits bone formation

Published:2005-08-25 Issue:13 Volume:19 Page:1842-1844
ISSN:0892-6638
Container-title:The FASEB Journal
language:en
Short-container-title:FASEB j.

Author:

Poole Kenneth E. S.¹,Van Bezooijen Rutger L.²³,Loveridge Nigel¹,Hamersma Herman⁴,Papapoulos Socrates E.²,Löwik Clemens W.²,Reeve Jonathan¹

Affiliation:

1. Bone Research GroupDepartment of MedicineUniversity of CambridgeAddenbrooke's Hospital Cambridge United Kingdom

2. Department of Endocrinology and Metabolic DiseasesLeiden University Medical Centre Leiden Netherlands

3. Department of Molecular Cell BiologyLeiden University Medical Centre Leiden Netherlands

4. South Africa

Funder

Medical Research Council

National Osteoporosis Society

European Commission

Publisher

Wiley

Subject

Genetics,Molecular Biology,Biochemistry,Biotechnology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1096/fj.05-4221fje

Reference35 articles.

1. The osteocyte

2. A quantitative evaluation of osteoblast-osteocyte relationships on growing endosteal surface of rabbit tibiae

3. The structure of bone tissues and the cellular control of their deposition;Marotti G.;Ital. J. Anat. Embryol.,1996

4. Does osteocyte formation cause the nonlinear refilling of osteons?

Cited by 816 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Estrogen and estrogen receptors mediate the mechanobiology of bone disease and repair;Bone;2024-11

2. Deletion of Asb15b gene can lead to a significant decrease in zebrafish intermuscular bone;Gene;2024-09

3. Emerging role of liver-bone axis in osteoporosis;Journal of Orthopaedic Translation;2024-09

4. Unraveling the molecular and immunological landscape: Exploring signaling pathways in osteoporosis;Biomedicine & Pharmacotherapy;2024-08

5. Wnt/β-catenin pathway as a potential target for Parkinson’s disease: a cohort study of romosozumab using routinely collected health data in Japan;Frontiers in Pharmacology;2024-07-22

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3